对比增强超音波市场－全球产业规模、份额、趋势、机会和预测，依产品、类型、最终用途、地区和竞争格局划分，2020-2030年预测

2024年全球对比增强超音波市场规模为22.7亿美元，预计到2030年将以4.65%的复合年增长率成长至29.8亿美元。对比增强超音波（CEUS）是一种诊断影像技术，它利用静脉注射的充气微泡来增强标准医学超音波检查中血流和组织血管的显像效果。此技术透过突显器官和病灶中的血管模式来提高诊断精度，通常能提供比传统超音波更清晰的影像。

主要市场驱动因素

全球慢性疾病负担日益加重，是对比增强超音波市场的重要驱动因素。心血管疾病、癌症和肝臟疾病等都需要准确且频繁的诊断影像，以便早期发现、分期和监测治疗。

主要市场挑战

全球熟练超音波医师的短缺对对比增强超音波市场的成长构成了重大挑战。对比增强超音波检查操作复杂，需要专业技能才能准确操作、撷取和解读影像。

主要市场趋势

人工智慧的整合显着提升了对比增强超音波技术，提高了影像分析和诊断能力。人工智慧演算法能够自动完成分割、异常检测并优化工作流程，从而提高准确性和效率，并有可能减少人为错误。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球对比增强超音波市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（设备、显影剂）
  • 按类型（非定向、定向）
  • 依最终用途（医院、诊所、门诊诊断中心）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美对比增强超音波市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲对比增强超音波市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区对比增强超音波市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲对比增强超音波市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲对比增强超音波市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球对比增强超音波市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Lantheus Holdings, Inc.
• General Electric Company
• Siemens Healthineers Company
• nanoPET Pharma GmbH
• ESAOTE SPA
• GE HealthCare Technologies, Inc.
• Koninklijke Philips NV
• Leriva SA

第十六章：策略建议

第17章调查会社について・免责事项

The Global Contrast Enhanced Ultrasound Market, valued at USD 2.27 Billion in 2024, is projected to experience a CAGR of 4.65% to reach USD 2.98 Billion by 2030. Contrast-enhanced ultrasound (CEUS) is a diagnostic imaging modality that utilizes intravenously administered, gas-filled microbubbles to enhance the visualization of blood flow and tissue vascularization during standard medical sonography. This technique improves diagnostic precision by accentuating vascular patterns in organs and lesions, often providing clearer images than conventional ultrasound.

Key Market Drivers

The rising global burden of chronic diseases is a significant market driver for Contrast Enhanced Ultrasound. Conditions like cardiovascular disease, cancer, and hepatic disorders require accurate and frequent diagnostic imaging for early detection, staging, and monitoring treatment. CEUS provides a non-invasive, radiation-free method to precisely assess tissue perfusion and vascularity, which is crucial for characterizing lesions and evaluating organ function. This capability assists clinicians in making timely patient management decisions.

Key Market Challenges

The global scarcity of skilled sonographers poses a significant challenge to the growth of the Contrast Enhanced Ultrasound market. The sophisticated nature of CEUS procedures requires specialized expertise for accurate operation, image acquisition, and interpretation. Without an adequate pool of trained professionals, healthcare facilities face limitations in adopting and fully utilizing this advanced imaging modality, regardless of its diagnostic benefits.

Key Market Trends

AI integration is significantly enhancing contrast-enhanced ultrasound by improving image analysis and diagnostic capabilities. Artificial intelligence algorithms automate segmentation, anomaly detection, and optimize workflow, thereby improving accuracy and efficiency and potentially reducing human error. This technological advance enables faster interpretation of complex images and supports early disease detection, leading to improved patient outcomes. According to Medical Device Network, in July 2023, UltraSight received FDA approval for its AI-based cardiac ultrasound guidance technology, enabling medical professionals without prior sonography experience to capture diagnostic-quality images at the point of care.

Key Market Players

• Lantheus Holdings, Inc.
• General Electric Company
• Siemens Healthineers Company
• nanoPET Pharma GmbH
• ESAOTE SPA
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Leriva SA

Report Scope:

In this report, the Global Contrast Enhanced Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contrast Enhanced Ultrasound Market, By Product:

• Equipment
• Contrast Agents

Contrast Enhanced Ultrasound Market, By Type:

• Non-targeted
• Targeted

Contrast Enhanced Ultrasound Market, By End use:

• Hospitals
• Clinics
• Ambulatory Diagnostic Centers

Contrast Enhanced Ultrasound Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Enhanced Ultrasound Market.

Available Customizations:

Global Contrast Enhanced Ultrasound Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contrast Enhanced Ultrasound Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Equipment, Contrast Agents)
  • 5.2.2. By Type (Non-targeted, Targeted)
  • 5.2.3. By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Contrast Enhanced Ultrasound Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By End use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Contrast Enhanced Ultrasound Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By End use
  • 6.3.2. Canada Contrast Enhanced Ultrasound Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By End use
  • 6.3.3. Mexico Contrast Enhanced Ultrasound Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By End use

7. Europe Contrast Enhanced Ultrasound Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By End use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Contrast Enhanced Ultrasound Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By End use
  • 7.3.2. France Contrast Enhanced Ultrasound Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By End use
  • 7.3.3. United Kingdom Contrast Enhanced Ultrasound Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By End use
  • 7.3.4. Italy Contrast Enhanced Ultrasound Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By End use
  • 7.3.5. Spain Contrast Enhanced Ultrasound Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By End use

8. Asia Pacific Contrast Enhanced Ultrasound Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By End use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Contrast Enhanced Ultrasound Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By End use
  • 8.3.2. India Contrast Enhanced Ultrasound Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By End use
  • 8.3.3. Japan Contrast Enhanced Ultrasound Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By End use
  • 8.3.4. South Korea Contrast Enhanced Ultrasound Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By End use
  • 8.3.5. Australia Contrast Enhanced Ultrasound Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By End use

9. Middle East & Africa Contrast Enhanced Ultrasound Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By End use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Contrast Enhanced Ultrasound Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By End use
  • 9.3.2. UAE Contrast Enhanced Ultrasound Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By End use
  • 9.3.3. South Africa Contrast Enhanced Ultrasound Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By End use

10. South America Contrast Enhanced Ultrasound Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By End use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Contrast Enhanced Ultrasound Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By End use
  • 10.3.2. Colombia Contrast Enhanced Ultrasound Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By End use
  • 10.3.3. Argentina Contrast Enhanced Ultrasound Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By End use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Contrast Enhanced Ultrasound Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Lantheus Holdings, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. General Electric Company
• 15.3. Siemens Healthineers Company
• 15.4. nanoPET Pharma GmbH
• 15.5. ESAOTE SPA
• 15.6. GE HealthCare Technologies, Inc.
• 15.7. Koninklijke Philips N.V.
• 15.8. Leriva SA

16. Strategic Recommendations

17. About Us & Disclaimer